The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Drobintseva A.O.

Saint Petersburg State Pediatric Medical University;
Saint Petersburg Research Institute of Phthisiopulmonology

Mironova E.S.

Saint Petersburg Research Institute of Phthisiopulmonology;
Saint Petersburg Institute of Bioregulation and Gerontology

Zubareva T.S.

Saint Petersburg Research Institute of Phthisiopulmonology;
Saint Petersburg Institute of Bioregulation and Gerontology

Krylova Yu.S.

Saint Petersburg Research Institute of Phthisiopulmonology;
First Saint Petersburg State Medical University named after. acad. I.P. Pavlov (Pavlov University)

Kvetnoy I.M.

St. Petersburg Research Institute of Phthisiopulmonology;
St. Petersburg State University

Paltsev M.A.

Lomonosov Moscow State University

Yablonskiy P.K.

St. Petersburg Research Institute of Phthisiopulmonology;
St. Petersburg State University

Modern approaches to studying the molecular mechanisms of lung functioning in normal and pathological conditions

Authors:

Drobintseva A.O., Mironova E.S., Zubareva T.S., Krylova Yu.S., Kvetnoy I.M., Paltsev M.A., Yablonskiy P.K.

More about the authors

Read: 1258 times


To cite this article:

Drobintseva AO, Mironova ES, Zubareva TS, Krylova YuS, Kvetnoy IM, Paltsev MA, Yablonskiy PK. Modern approaches to studying the molecular mechanisms of lung functioning in normal and pathological conditions. Russian Journal of Archive of Pathology. 2024;86(2):58‑64. (In Russ.)
https://doi.org/10.17116/patol20248602158

References:

  1. Cardoso WV, Whitsett JA. Resident cellular components of the lung: developmental aspects. Proc Am Thorac Soc. 2008;5(7):767-771.  https://doi.org/10.1513/pats.200803-026HR
  2. Edmondson R, Broglie JJ, Adcock AF, Yang L. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014;12(4):207-218.  https://doi.org/10.1089/adt.2014.573
  3. Langhans SA. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Front Pharmacol. 2018;9:6.  https://doi.org/10.3389/fphar.2018.00006
  4. Leung CM, de Haan P, Ronaldson-Bouchard K, Kim CA, Ko J, Rho HS, Habibovic P, Jeon NL, Takayama S, Shuler ML, et al. A guide to the organ-on-a-chip. Nat Rev Methods Primers. 2022;2:33.  https://doi.org/10.1038/s43586-022-00118-6
  5. Francis I, Shrestha J, Paudel KR, Hansbro PM, Warkiani ME, Saha SC. Recent advances in lung-on-a-chip models. Drug Discov Today. 2022;27(9):2593-2602. https://doi.org/10.1016/j.drudis.2022.06.004
  6. Benam KH, Mazur M, Choe Y, Ferrante TC, Novak R, Ingber DE. Human lung small airway-on-a-chip protocol. Methods Mol Biol. 2017;1612:345-365.  https://doi.org/10.1007/978-1-4939-7021-6_25
  7. Huang D, Liu T, Liao J, Maharjan S, Xie X, Pérez M, Anaya I, Wang S, Tirado Mayer A, Kang Z, et al. Reversed-engineered human alveolar lung-on-a-chip model. Proc Natl Acad Sci U S A. 2021;118(19):e2016146118. https://doi.org/10.1073/pnas.2016146118
  8. Huh DD. A human breathing lung-on-a-chip. Ann Am Thorac Soc. 2015;12(suppl 1):S42-S44.  https://doi.org/10.1513/AnnalsATS.201410-442MG
  9. Lin KC, Yen CZ, Yang JW, Chung JHY, Chen GY. Airborne toxicological assessment: the potential of lung-on-a-chip as an alternative to animal testing. Mater Today Adv. 2022;14:100216. https://doi.org/10.1016/j.mtadv.2022.100216
  10. Shrestha J, Bazaz SR, Es HA, Azari DY, Thierry B, Warkiani ME, Ghadidri M. Lung-on-a-chip: the future of respiratory disease models and pharmacological studies. Crit Rev Biotechnol. 2020;40(2):213-230.  https://doi.org/10.1080/07388551.2019.1710458
  11. Kumar B, Kashyap N, Avinash A, Chevvuri R, Sagar MK, Shrikant K. The composition, function and role of saliva in maintaining oral health: a review. Int J Contemp Dent Med Rev. 2017;2017:011217. https://doi.org/10.15713/ins.ijcdmr.121
  12. Kaczor-Urbanowicz KE, Carreras-Presas CM, Aro K, Tu M, Garcia-Godoy F, Wong DT. Saliva diagnostics — current views and directions. Exp Biol Med (Maywood). 2017;242(5):459-472.  https://doi.org/10.1177/1535370216681550
  13. Pal’tsev MA, Saraev GB, Bunin VA, Belushkina NN, Popravka ES, Lin’kova NS, Kozlov KL, Sedova EV, Mursalov SU, Kvetnoi IM. Saliva as a biological object for non-invasive molecular diagnostics of cardiovascular diseases. Molekulyarnaya Meditsina. 2018;16(5):3-8. (In Russ.). https://doi.org/10.29296/24999490-2018-05-01
  14. Bel’skaya LV, Kosenok VK, Massard G. Sialic acid in the primary and differential diagnosis of lung cancer. Voprosy Onkologii. 2017;63(6):926-932. (In Russ.). https://doi.org/10.37469/0507-3758-2017-63-6-926-932
  15. Bel’skaya LV, Sarf EA, Kosenok VK, Gundyrev IA. Biochemical markers of saliva in lung cancer: diagnostic and prognostic perspectives. Diagnostics (Basel). 2020;10(4):186.  https://doi.org/10.3390/diagnostics10040186
  16. Cui Y, Yang M. Zhu J, Zhang H, Duan Z, Wang S, Liao Z, Liu W. Developments in diagnostic applications of saliva in human organ diseases. Med Nov Technol Devices. 2022;13:100115. https://doi.org/10.1016/j.medntd.2022.100115
  17. Xiao H, Zhang L, Zhou H, Lee JM, Garon EB, Wong DT. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics. 2012;11(2):M111.012112. https://doi.org/10.1074/mcp.M111.012112
  18. Grootveld M, Page G, Bhogadia M, Hunwin K, Edgar M. Updates and original case studies focused on the NMR-linked metabolomics analysis of human oral fluids part iii: implementations for the diagnosis of non-cancerous disorders, both oral and systemic. Metabolites. 2023;13(1):66.  https://doi.org/10.3390/metabo13010066
  19. Takamori S, Ishikawa S, Suzuki J, Oizumi H, Uchida T, Ueda S, Edamatsu K, Iino M, Sugimoto M. Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: a preliminary study. Thorac Cancer. 2021;13(3):460-465.  https://doi.org/10.1111/1759-7714.14282
  20. Bayat P, Nosrati R, Alibolandi M, Rafatpanah H, Abnous K, Khedri M, Ramezani M. SELEX methods on the road to protein targeting with nucleic acid aptamers. Biochimie. 2018;154:132-155.  https://doi.org/10.1016/j.biochi.2018.09.001
  21. Dunn MR, Jimenez RM, Chaput JC. Analysis of aptamer discovery and technology. Nat Rev Chem. 2017;1:0076. https://doi.org/10.1038/S41570-017-0076
  22. Zamay GS, Kolovskaya OS, Zamay TN, Glazyrin YE, Krat AV, Zubkova O, Spivak E, Wehbe M, Gargaun A, Muharemagic D, et al. Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood. Mol Ther. 2015;23(9): 1486-1496. https://doi.org/10.1038/mt.2015.108
  23. Krat AV, Zamai TN, Zamai GS, Kolovskaya OS, Grigor’eva VL, Kichkailo AS, Zukov RA. The use of DNA aptamers in the estimation of the prevalence the tumor process in lung cancer patients. Siberian Medical Review. 2016;(5):96-98. (In Russ.).
  24. Morozov D, Mironov V, Moryachkov R, Shchugoreva IA, Artyushenko PV, Zamay GS, Kolovskaya OS, Zamay TN, Krat AV, Molodenskiy DS, et al. The role of SAXS and molecular simulations in 3D structure elucidation of a DNA aptamer against lung cancer. Mol Ther Nucleic Acids. 2021;25:316-327.  https://doi.org/10.1016/j.omtn.2021.07.015
  25. Gruber JJ, Geller B, Lipchik AM, Chen J, Salahudeen AA, Ram AN, Ford JM, Kuo CJ, Snyder MP. HAT1 coordinates histone production and acetylation via H4 promoter binding. Mol Cell. 2019;75(4):711-724.e5.  https://doi.org/10.1016/j.molcel.2019.05.034
  26. Klett-Mingo JI, Pinto-Díez C, Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M, Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM, Martín ME. Potential therapeutic use of aptamers against HAT1 in lung cancer. Cancers (Basel). 2022;15(1):227.  https://doi.org/10.3390/cancers15010227
  27. Luk’yanov PA, Zhuravleva NV. Modern glycobiology and medicine. Vestnik DVO RAN. 2004;(3):24-34. (In Russ.).
  28. Petrov D, Margreitter C, Grandits M, Oostenbrink C, Zagrovic B. A systematic framework for molecular dynamics simulations of protein post-translational modifications. PLoS Comput Biol. 2013; 9(7):e1003154. https://doi.org/10.1371/journal.pcbi.1003154
  29. Peixoto A, Relvas-Santos M, Azevedo R, Santos LL, Ferreira JA. Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks. Front Oncol. 2019;9:380.  https://doi.org/10.3389/fonc.2019.00380
  30. Meszaros B, Jarvas G, Kun R, Szabó M, Csánky E, Abonyi J, Guttman A. Machine learning based analysis of human serum N-glycome alterations to follow up lung tumor surgery. Cancers (Basel). 2020;12(12):3700. https://doi.org/10.3390/cancers12123700
  31. Pavić T, Dilber D, Kifer D, Selak N, Keser T, Ljubičić Đ, Vukić Dugac A, Lauc G, Rumora L, Gornik O. N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease. J Transl Med. 2018;16(1):323.  https://doi.org/10.1186/s12967-018-1695-0
  32. Komaromy A, Reider B, Jarvas G, Guttman A. Glycoprotein biomarkers and analysis in chronic obstructive pulmonary disease and lung cancer with special focus on serum immunoglobulin G. Clin Chim Acta. 2020;506:204-213.  https://doi.org/10.1016/j.cca.2020.03.041
  33. Service RF. Bioengineering. Lung-on-a-chip breathes new life into drug discovery. Science. 2012;338(6108):731.  https://doi.org/10.1126/science.338.6108.731

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.